u/FastStomach31

The author argues ORIS is deeply undervalued because its ~$6M market cap is far below its ~$50M cash, it has no debt, positive net income, and roughly 4M shares outstanding if nearly all warrants were exercised. They see minimal near-term dilution risk because management appears to want to maintain Nasdaq access and defend the $1 minimum bid, with a possible official Nasdaq compliance release later this week and four acquisition LOIs as catalysts. The main stated risk is that dilution near $1 could trigger another investor panic and price plummet, potentially risking delisting. The author reports being long 75k shares and expects a pure value-based 10x from current pricing.

The author bought shares of RDAC, a highly redeemed SPAC with a low tradable float. He argues the low float makes it primed for a major short squeeze and could push the price to at least $50, citing the prior AFJK rally and ASPC potential. The catalyst is the squeeze itself, though no timeframe is stated.